Protara Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Protara Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2013 to Q3 2024.
  • Protara Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.3M, a 15.2% decline year-over-year.
  • Protara Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$45.9M, a 36.3% increase year-over-year.
  • Protara Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$43.6M, a 35% increase from 2022.
  • Protara Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$67.1M, a 41.2% decline from 2021.
  • Protara Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$47.5M, a 37.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$45.9M -$12.3M -$1.63M -15.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$44.3M -$10.7M +$1.48M +12.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$45.7M -$11.9M -$2.12M -21.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$43.6M -$11M +$28.5M +72.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$72.1M -$10.7M -$2.73M -34.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$69.4M -$12.1M -$3.44M -39.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$65.9M -$9.73M +$1.14M +10.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$67.1M -$39.5M -$29.2M -284% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$37.8M -$7.97M +$2.86M +26.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$40.7M -$8.71M +$4.09M +32% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$44.8M -$10.9M +$2.71M +19.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$47.5M -$10.3M -$1.33M -14.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 -$46.2M -$10.8M -$2.77M -34.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$43.4M -$12.8M -$5.53M -76.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$37.9M -$13.6M -$3.42M -33.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$34.4M -$8.96M -$6.44M -256% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 -$28M -$8.06M -$5.71M -242% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$22.3M -$7.27M -$5.84M -409% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$16.5M -$10.2M -$8.63M -565% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$7.83M -$2.52M +$2.87M +53.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$10.7M -$2.35M +$2.27M +49.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$13M -$1.43M +$3.57M +71.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$16.5M -$1.53M +$4.84M +76% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$21.4M -$5.39M +$205K +3.67% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$21.6M -$4.62M +$7.68M +62.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 -$29.3M -$5M +$986K +16.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$30.2M -$6.37M +$115K +1.78% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$30.4M -$5.59M +$1.28M +18.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$31.6M -$12.3M -$5.14M -71.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$26.5M -$5.99M +$1.87M +23.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$28.4M -$6.48M +$339K +4.97% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$28.7M -$6.87M -$679K -11% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-13
Q3 2016 -$28M -$7.17M -$2.08M -41% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$25.9M -$7.85M -$2.87M -57.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$23.1M -$6.82M -$2.2M -47.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$20.9M -$6.19M -$2.91M -89% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 -$18M -$5.08M -$5.22M -3893% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$12.7M -$4.98M -$2.47M -98.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$10.3M -$4.62M -$2.69M -139% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$7.58M -$3.27M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $134K +$2.05M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.51M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$1.93M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 -$1.91M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.